Published on:

Fen-Phen Class Action Settlement Now Valued at $7.5 Billion

The historic Fen-Phen settlement is now valued at $7.5 billion according to the plaintiffs’ attorneys managing the settlement payout. Fen-Phen was a popular diet drug and is the most notable of any prescription drug liability and injury suit. Fen-Phen is actually a combination of two drugs, fenfluramine (Pondimin) and Phentermine. Phentermine is still available today and is sold under several different brand names.

The Fen-Phen class action is unique because it offered a three-tiered system of initial opt-outs, intermediate opt-outs, and preserved a back-end option for injured plaintiffs to sue if they develop heart valve disease by as late as 2015, among other new ideas. This new system was designed to avoid the pitfalls seen in previous asbestos and GM Truck class action suits.

For the full article, click here.